Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod. Jander S, Turowski B, Kieseier BC, Hartung H-P Mult Scler. 2012 Nov; 18(11):1650-2. PMID: 23100527. Abstract CommentRecommendBookmarkWatch